Two biotechs raise a combined $556M in latest spurt of IPOs
Source: BioPharma Dive - Latest News
Seaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.